# Older Adults Turn to Cannabis Primarily for Symptom Management – MPR – eMPR.com > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management-mpr-empr-com/ > **Published:** 2026-05-18T20:07:53-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:54:57-04:00 > **Clinical Summary:** How older adults use cannabis for symptom management. Clinical evidence, safety concerns, and physician guidance for geriatric cannabis counseling. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AgingPainSleepAnxietyResearchSafetyMental Health Why This Matters Clinicians treating older adults need to understand that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in this population is primarily motivated by symptom management rather than recreational use, which may indicate undertreated pain, sleep disorders, or anxiety that warrant conventional medical evaluation first. This awareness helps providers engage in non-judgmental conversations about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), assess for drug interactions with polypharmacy common in older patients, and guide safer use patterns or recommend evidence-based alternatives. Knowledge of older adults’ specific reasons for cannabis use can inform [patient counseling](https://cedclinic.com/stroke-risk-assessment-substance-use/) and improve shared decision-making about both cannabis and conventional symptom management options. Clinical Summary A recent study published in JAMA Network Open examined cannabis use patterns among older adults and found that symptom management, particularly pain relief, is the primary driver for use in this population. Older adults frequently report perceiving cannabis as more effective or better tolerated than conventional medications, often turning to it as an alternative or adjunctive therapy for chronic conditions. This trend reflects a significant gap between patient preferences and evidence-based prescribing practices, as many older adults may lack guidance from their healthcare providers about cannabis efficacy, drug interactions, and safety risks specific to aging populations. For clinicians, this underscores the importance of proactively discussing cannabis use during medication reviews, since older patients may not volunteer this information and may be concurrently taking medications that interact with cannabinoids. Understanding older adults’ motivations for cannabis use can help physicians better address underlying symptoms with evidence-based treatments while mitigating potential harms including falls, cognitive effects, and polypharmacy complications. Clinicians should initiate open conversations about cannabis use with older patients and, where appropriate, collaborate on evidence-based pain and symptom management strategies that may reduce reliance on cannabis or clarify its role in the treatment plan. Dr. Caplan’s Take “What we’re seeing in my practice is that older patients are using cannabis not for recreational purposes but as a pragmatic tool for pain, sleep, and nausea when conventional options have failed or caused intolerable [side effects](https://cedclinic.com/cannabis-intoxication-memory-disruption/), and that distinction matters because it changes how we should be counseling them on dosing, drug interactions, and monitoring for cognitive effects.” Clinical Perspective As cannabis use among older adults increases, understanding their motivations is essential for [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/), though this shift reflects both genuine symptom burden and potential gaps in conventional treatment options. The primary driver of use in this population appears to be symptom management—particularly for pain, sleep, and anxiety—which aligns with common geriatric complaints but raises questions about whether older patients have exhausted evidence-based alternatives or are simply seeking different efficacy or tolerability profiles. Clinicians should recognize important confounders: older adults may perceive cannabis as “natural” and therefore safer than pharmaceuticals, may have limited access to or experience with other therapies, and may not fully appreciate cannabis-specific risks such as drug interactions, cognitive effects, or falls in this high-risk population. The lack of robust efficacy data for many cannabis products, combined with individual variability in metabolism and response, further complicates the clinical picture. Given these considerations, older adults using 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Older%20Adults%20Turn%20to%20Cannabis%20Primarily%20for%20Symptom%20Management%20-%20MPR%20-%20eMPR.com%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55397)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55397)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Older%20Adults%20Turn%20to%20Cannabis%20Primarily%20for%20Symptom%20Management%20-%20MPR%20-%20eMPR.com%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55397)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Society – Cannabis use among older adults is rising rapidly—especially for chronic pain …](https://cedclinic.com/cannabis-use-drug-interactions-older-adults/) - [Cannabis edibles in dementia care: What families should know – AZ Family](https://cedclinic.com/cannabis-use-in-dementia-care-families-know/) - [Seniors make up more than 25% of adult use cannabis market in Delaware](https://cedclinic.com/cannabis-drug-interactions-seniors-market-trends/) 📰 Source: [https://www.empr.com/news/older-adults-turn-to-cannabis-primarily-for-symptom-management/](https://www.empr.com/news/older-adults-turn-to-cannabis-primarily-for-symptom-management/) Further Reading Cannabis Policy Wire[Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I](https://cedclinic.com/mdmb-4en-pinaca-schedule-i-placement/) CED Clinic Blog[Fear of recurrence, secondary cancers, and health problems in long-term survivors of childhood cancer: Findings from a Canadian cohort.](https://cedclinic.com/fear-of-recurrence-secondary-cancers-and-health-problems-in-long-term-survi/) CED Clinic Blog[Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days.](https://cedclinic.com/associations-of-cannabis-use-other-substances-and-lifestyle-choices-on-anxi/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).